In this study, we generated a cellular model of the FLT3-ITD mutation using the CRISPR-Cas9 system and a human myeloid leukemia cell line, K562 (Supplemental Figs. S1a, b and S2a–d). The gene discussed is FLT3; the disease is myeloid leukemia.